Raf Roelands

Raf Roelands is a seasoned investment professional specializing in Medtech and Digital Health sectors, currently serving as a Partner at HERAN Partners since May 2022. In addition, Raf holds multiple leadership roles, including Investment Director and Board Observer at Broken String Biosciences, where a technology platform focuses on genome editing technologies. Raf is also a Board Member at Hypervision Surgical, contributing to innovations in intraoperative imaging systems, and at ONTOFORCE, which develops semantic search technology. Previous experience includes serving as Senior Investment Manager at Korys and roles across OMX Ventures, reMYND NV, Protealis, and MRM Health. Raf's academic background includes a Master of Science in Biochemistry from KU Leuven and an MBA from Vlerick Business School.